These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 311335)

  • 1. Sera from volunteers immunized by planned blood transfusions as source of DR cytotoxic typing reagents.
    Belvedere M; Richiardi P; Curtoni ES; Pellegrino MA; Ferrone S
    Immunol Commun; 1979; 8(1):93-106. PubMed ID: 311335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance and evolution of anti-Da (B cell-specific) antibodies after planned immunizations.
    Belvedere M; Richiardi P; Savi M; Curtoni ES; Carbonara AO; Ceppellini R
    Tissue Antigens; 1978 Feb; 11(2):153-62. PubMed ID: 347631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and use of high titered anti-HLA-DR sera in PHA-blast complement fixation and B-lymphocytotoxicity techniques.
    Lepage V; Gaudy Y; Terrier E; Dausset J; Colombani J
    Tissue Antigens; 1981 Jan; 17(1):37-42. PubMed ID: 6166083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of anti-W24 xenoantisera in rabbits.
    Ferrone S; Pellegrino MA; Billing R; Terasaki PI; Reisfeld RA
    Tissue Antigens; 1975 Feb; 5(1):41-7. PubMed ID: 1138440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenoantisera to allotypic specificities of HLA-A and B antigens. Serological characterization.
    Richiardi P; Pellegrino MA; Ferrone S
    Transplantation; 1979 Oct; 28(4):333-8. PubMed ID: 92080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenoantisera to human DR antigens: Serological and immunochemical characterization.
    Ferrone S; Naeim F; Indiveri F; Walker LE; Pellegrino MA
    Immunogenetics; 1978 Dec; 7(1):349-58. PubMed ID: 21302089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenoantisera to DRw allospecificities.
    Belvedere M; Pellegrino MA; Ferrone S
    J Immunogenet; 1980 Apr; 7(2):167-72. PubMed ID: 6155413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisera recognising HLA-A, -B and DRW antigens raised in rhesus monkeys.
    Barnstable CJ; Snary D; Crumpton MJ; Balner H; Bodmer WF
    Tissue Antigens; 1980 May; 15(5):407-18. PubMed ID: 6160645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planned immunization of human volunteers with HLA-DR incompatible lymphocytes I. Serological aspects.
    Madsen M; Johnsen HE; Kristensen T; Jørgensen F; Lamm LU; Kissmeyer-Nielsen F
    Tissue Antigens; 1982 Jul; 20(1):33-46. PubMed ID: 6957026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible detection of HLA-DR alloantigenic specificities in man with unabsorbed rabbit antisera.
    Solheim BG; Fuks A; Smith L; Strominger JL; Thorsby E
    Scand J Immunol; 1978; 8(1):15-20. PubMed ID: 81513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives: reactivity with the HLA antigenic molecular complex.
    Messner RP; De Horatius R; Ferrone S
    Arthritis Rheum; 1980 Mar; 23(3):265-72. PubMed ID: 6153898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibody response to histocompatibility antigens in hemodialysis patients subjected to planned whole-blood transfusions].
    Fagiolo U; Corsano A; Antonello A; Venturi-Pasini C; Dal Lago O; Indiveri F
    Minerva Chir; 1980 May; 35(10):701-4. PubMed ID: 7005724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoidance of certain systematic pitfalls in the detection of HLA-DR antibodies defining find specificities.
    Müller C; Fink D; Müller G; Wernet P
    Tissue Antigens; 1980 Sep; 16(3):244-53. PubMed ID: 6970429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell antigens of the HLA system: a simple serotyping technique based on non-cytotoxic anti-beta2-microglobulin reagents.
    Bernoco D; Bernoco M; Ceppellini R; Poulik MD; Leeuwen A; Rood JJ
    Tissue Antigens; 1976 Oct; 8(4):253-60. PubMed ID: 62417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The search for anti-B cell antibodies and HLA-DR typing in Montpellier].
    Seignalet J
    Rev Fr Transfus Immunohematol; 1980 Sep; 23(4):411-25. PubMed ID: 6969919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences in the capacity of HLA sera to react with T- and B-lymphocyte populations].
    Zotikov EA; Tananov AT
    Biull Eksp Biol Med; 1976 Jun; 81(6):698-9. PubMed ID: 60152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fab2 fragments from HLA xenoantisera specifically block cytolysis mediated by HLA-AB alloantisera.
    Belvedere M; Richiardi P; Pellegrino MA; Ferrone S
    J Immunogenet; 1980 Jun; 7(3):215-9. PubMed ID: 6157749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of DR xenoantisera in a cytotoxic test with human complement.
    Belvedere M; Olivetti E; Pellegrino MA; Ferrone S
    Transplant Proc; 1979 Jun; 11(2):1327-8. PubMed ID: 314179
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.
    Burlingham WJ; Pan MH; Mason B; Ceman S; Sollinger HW
    Transplantation; 1988 Jun; 45(6):1066-71. PubMed ID: 3289148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible effects of non-HLA antibodies in common typing sera on HLA antigen frequency data in leukemia.
    Pollack MS; DuBois D
    Cancer; 1977 Jun; 39(6):2348-54. PubMed ID: 301430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.